DMT psychedelic therapy for substance misuse
Explore the latest meta‐analysis on DMT psychedelic therapy for substance misuse, its promising effect sizes, and the cautionary caveats that temper enthusiasm.
Psilocybin, ketamine, MDMA and related research, explained.
Explore the latest meta‐analysis on DMT psychedelic therapy for substance misuse, its promising effect sizes, and the cautionary caveats that temper enthusiasm.
Donald Hoffman and Andrew Gallimore propose falsifiable experiments for the beings people report meeting on DMT. No results exist yet, and the researchers say hallucination remains the default explanation.
A systematic review examines psychedelic therapy for substance use disorder, highlighting potential benefits and noting study heterogeneity and risk of bias.
New mega-review maps how yoga, psychedelics, VR, and even past-life hypnosis all appear to pry open the same neural lock on the mind.
A sweeping preprint claims 25+ disciplines can “remodel” the subconscious. We dig into the data to find what actually works, what’s still fantasy, and why the wildest therapy of all—past-life regression—might deserve its first real study.
Float tanks can trigger “aquahenosis,” an altered state that mirrors psilocybin trips—no drugs required. Here’s what 75 anxious volunteers felt inside the dark, silent water.
A systematic review of 123 studies finds mirror-gazing, ketamine, and cannabis produce the strongest experimentally induced dissociation.
Explore the early, contested research on psychedelics and autism, understanding the neurobiology and the cautious approach to potential therapeutic…
Weizmann scientists engineered tobacco plants to make five psychedelic compounds — psilocybin, DMT and more — a possible sustainable route for research.
A systematic review finds consistent frontal cortex abnormalities in schizophrenia and autism using fractal analysis, but methodological gaps limit clinical translation.